Company / Return on Equity (ROE)
Celcuity Inc. Return on Equity (ROE) History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-96.7%
FY2024
5-year range
-96.7% / -30.2%
FY2020-FY2024
Trend
-111.9%
vs FY2023
Sector context
#145 of 147
Health Care
What the data says
Celcuity Inc. reports negative total equity of -96.7% in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-96.7% in FY2024 with a 5-year CAGR of -58.5%.
Declined from -30.2% to -96.7% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -53.6pp
- 5-Year Change
- -58.5pp
- 10-Year Change
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 147This company -96.7% Sector average -3.3%
▼
-2836.1% below sector average
Key checks
Key Insights
- In FY2024, return on equity (roe) decreased 111.9% year-over-year.
- Currently 93.4pp below the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -96.7% | -111.9% |
| FY2023 | -45.6% | -51.2% |
| FY2022 | -30.2% | +30.0% |
| FY2021 | -43.1% | +46.8% |
| FY2020 | -81.0% | -112.3% |
| FY2019 | -38.1% | -29.2% |
| FY2018 | -29.5% | -48.1% |
| FY2017 | -19.9% | +66.2% |
| FY2016 | -59.0% | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026